IVD抗体の世界市場見通し2023年-2029年

◆英語タイトル:IVD Antibody Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書(MMG23LY7770)◆商品コード:MMG23LY7770
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2023年7月
◆ページ数:75
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器&消耗品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global IVD Antibody Market 調査レポートは次の情報を含め、グローバルにおけるのIVD抗体市場規模と予測を収録しています。・世界のIVD抗体市場:売上、2018年-2023年、2024年-2029年
・世界のIVD抗体市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のIVD抗体市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「mAb」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

IVD抗体のグローバル主要企業は、BD PharMingen、 Abcam、 R&D Systems、 Cell Signaling Technology、 Affymatrix、 BioLegend、 Santa Cruz Biotechnologies、 Beckman Coulter、 Roche/Ventanaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、IVD抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のIVD抗体市場:タイプ別、2018年-2023年、2024年-2029年
世界のIVD抗体市場:タイプ別市場シェア、2022年
・mAb、pAb、rAb

世界のIVD抗体市場:用途別、2018年-2023年、2024年-2029年
世界のIVD抗体市場:用途別市場シェア、2022年
・RIA、ELISA、CLIA、LFIA、その他

世界のIVD抗体市場:地域・国別、2018年-2023年、2024年-2029年
世界のIVD抗体市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるIVD抗体のグローバル売上、2018年-2023年
・主要企業におけるIVD抗体のグローバル売上シェア、2022年
・主要企業におけるIVD抗体のグローバル販売量、2018年-2023年
・主要企業におけるIVD抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
BD PharMingen、 Abcam、 R&D Systems、 Cell Signaling Technology、 Affymatrix、 BioLegend、 Santa Cruz Biotechnologies、 Beckman Coulter、 Roche/Ventana

*************************************************************

・調査・分析レポートの概要
IVD抗体市場の定義
市場セグメント
世界のIVD抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のIVD抗体市場規模
世界のIVD抗体市場規模:2022年 VS 2029年
世界のIVD抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのIVD抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のIVD抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:mAb、pAb、rAb
IVD抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:RIA、ELISA、CLIA、LFIA、その他
IVD抗体の用途別グローバル売上・予測

・地域別市場分析
地域別IVD抗体市場規模 2022年と2029年
地域別IVD抗体売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報(企業概要、事業概要、主要製品、売上、ニュースなど)
BD PharMingen、 Abcam、 R&D Systems、 Cell Signaling Technology、 Affymatrix、 BioLegend、 Santa Cruz Biotechnologies、 Beckman Coulter、 Roche/Ventana
...

IVD Antibody
This report aims to provide a comprehensive presentation of the global market for IVD Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Antibody. This report contains market size and forecasts of IVD Antibody in global, including the following market information:
Global IVD Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global IVD Antibody Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five IVD Antibody companies in 2022 (%)
The global IVD Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
mAb Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of IVD Antibody include BD PharMingen, Abcam, R&D Systems, Cell Signaling Technology, Affymatrix, BioLegend, Santa Cruz Biotechnologies, Beckman Coulter and Roche/Ventana, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IVD Antibody manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IVD Antibody Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global IVD Antibody Market Segment Percentages, by Type, 2022 (%)
mAb
pAb
rAbs
Global IVD Antibody Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global IVD Antibody Market Segment Percentages, by Application, 2022 (%)
RIA
ELISA
CLIA
LFIA
Other
Global IVD Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global IVD Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IVD Antibody revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies IVD Antibody revenues share in global market, 2022 (%)
Key companies IVD Antibody sales in global market, 2018-2023 (Estimated), (K Units)
Key companies IVD Antibody sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD PharMingen
Abcam
R&D Systems
Cell Signaling Technology
Affymatrix
BioLegend
Santa Cruz Biotechnologies
Beckman Coulter
Roche/Ventana
Outline of Major Chapters:
Chapter 1: Introduces the definition of IVD Antibody, market overview.
Chapter 2: Global IVD Antibody market size in revenue and volume.
Chapter 3: Detailed analysis of IVD Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IVD Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global IVD Antibody capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 IVD Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IVD Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IVD Antibody Overall Market Size
2.1 Global IVD Antibody Market Size: 2022 VS 2029
2.2 Global IVD Antibody Revenue, Prospects & Forecasts: 2018-2029
2.3 Global IVD Antibody Sales: 2018-2029
3 Company Landscape
3.1 Top IVD Antibody Players in Global Market
3.2 Top Global IVD Antibody Companies Ranked by Revenue
3.3 Global IVD Antibody Revenue by Companies
3.4 Global IVD Antibody Sales by Companies
3.5 Global IVD Antibody Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 IVD Antibody Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers IVD Antibody Product Type
3.8 Tier 1, Tier 2 and Tier 3 IVD Antibody Players in Global Market
3.8.1 List of Global Tier 1 IVD Antibody Companies
3.8.2 List of Global Tier 2 and Tier 3 IVD Antibody Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global IVD Antibody Market Size Markets, 2022 & 2029
4.1.2 mAb
4.1.3 pAb
4.1.4 rAbs
4.2 By Type – Global IVD Antibody Revenue & Forecasts
4.2.1 By Type – Global IVD Antibody Revenue, 2018-2023
4.2.2 By Type – Global IVD Antibody Revenue, 2024-2029
4.2.3 By Type – Global IVD Antibody Revenue Market Share, 2018-2029
4.3 By Type – Global IVD Antibody Sales & Forecasts
4.3.1 By Type – Global IVD Antibody Sales, 2018-2023
4.3.2 By Type – Global IVD Antibody Sales, 2024-2029
4.3.3 By Type – Global IVD Antibody Sales Market Share, 2018-2029
4.4 By Type – Global IVD Antibody Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IVD Antibody Market Size, 2022 & 2029
5.1.2 RIA
5.1.3 ELISA
5.1.4 CLIA
5.1.5 LFIA
5.1.6 Other
5.2 By Application – Global IVD Antibody Revenue & Forecasts
5.2.1 By Application – Global IVD Antibody Revenue, 2018-2023
5.2.2 By Application – Global IVD Antibody Revenue, 2024-2029
5.2.3 By Application – Global IVD Antibody Revenue Market Share, 2018-2029
5.3 By Application – Global IVD Antibody Sales & Forecasts
5.3.1 By Application – Global IVD Antibody Sales, 2018-2023
5.3.2 By Application – Global IVD Antibody Sales, 2024-2029
5.3.3 By Application – Global IVD Antibody Sales Market Share, 2018-2029
5.4 By Application – Global IVD Antibody Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global IVD Antibody Market Size, 2022 & 2029
6.2 By Region – Global IVD Antibody Revenue & Forecasts
6.2.1 By Region – Global IVD Antibody Revenue, 2018-2023
6.2.2 By Region – Global IVD Antibody Revenue, 2024-2029
6.2.3 By Region – Global IVD Antibody Revenue Market Share, 2018-2029
6.3 By Region – Global IVD Antibody Sales & Forecasts
6.3.1 By Region – Global IVD Antibody Sales, 2018-2023
6.3.2 By Region – Global IVD Antibody Sales, 2024-2029
6.3.3 By Region – Global IVD Antibody Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America IVD Antibody Revenue, 2018-2029
6.4.2 By Country – North America IVD Antibody Sales, 2018-2029
6.4.3 US IVD Antibody Market Size, 2018-2029
6.4.4 Canada IVD Antibody Market Size, 2018-2029
6.4.5 Mexico IVD Antibody Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe IVD Antibody Revenue, 2018-2029
6.5.2 By Country – Europe IVD Antibody Sales, 2018-2029
6.5.3 Germany IVD Antibody Market Size, 2018-2029
6.5.4 France IVD Antibody Market Size, 2018-2029
6.5.5 U.K. IVD Antibody Market Size, 2018-2029
6.5.6 Italy IVD Antibody Market Size, 2018-2029
6.5.7 Russia IVD Antibody Market Size, 2018-2029
6.5.8 Nordic Countries IVD Antibody Market Size, 2018-2029
6.5.9 Benelux IVD Antibody Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia IVD Antibody Revenue, 2018-2029
6.6.2 By Region – Asia IVD Antibody Sales, 2018-2029
6.6.3 China IVD Antibody Market Size, 2018-2029
6.6.4 Japan IVD Antibody Market Size, 2018-2029
6.6.5 South Korea IVD Antibody Market Size, 2018-2029
6.6.6 Southeast Asia IVD Antibody Market Size, 2018-2029
6.6.7 India IVD Antibody Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America IVD Antibody Revenue, 2018-2029
6.7.2 By Country – South America IVD Antibody Sales, 2018-2029
6.7.3 Brazil IVD Antibody Market Size, 2018-2029
6.7.4 Argentina IVD Antibody Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa IVD Antibody Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa IVD Antibody Sales, 2018-2029
6.8.3 Turkey IVD Antibody Market Size, 2018-2029
6.8.4 Israel IVD Antibody Market Size, 2018-2029
6.8.5 Saudi Arabia IVD Antibody Market Size, 2018-2029
6.8.6 UAE IVD Antibody Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BD PharMingen
7.1.1 BD PharMingen Company Summary
7.1.2 BD PharMingen Business Overview
7.1.3 BD PharMingen IVD Antibody Major Product Offerings
7.1.4 BD PharMingen IVD Antibody Sales and Revenue in Global (2018-2023)
7.1.5 BD PharMingen Key News & Latest Developments
7.2 Abcam
7.2.1 Abcam Company Summary
7.2.2 Abcam Business Overview
7.2.3 Abcam IVD Antibody Major Product Offerings
7.2.4 Abcam IVD Antibody Sales and Revenue in Global (2018-2023)
7.2.5 Abcam Key News & Latest Developments
7.3 R&D Systems
7.3.1 R&D Systems Company Summary
7.3.2 R&D Systems Business Overview
7.3.3 R&D Systems IVD Antibody Major Product Offerings
7.3.4 R&D Systems IVD Antibody Sales and Revenue in Global (2018-2023)
7.3.5 R&D Systems Key News & Latest Developments
7.4 Cell Signaling Technology
7.4.1 Cell Signaling Technology Company Summary
7.4.2 Cell Signaling Technology Business Overview
7.4.3 Cell Signaling Technology IVD Antibody Major Product Offerings
7.4.4 Cell Signaling Technology IVD Antibody Sales and Revenue in Global (2018-2023)
7.4.5 Cell Signaling Technology Key News & Latest Developments
7.5 Affymatrix
7.5.1 Affymatrix Company Summary
7.5.2 Affymatrix Business Overview
7.5.3 Affymatrix IVD Antibody Major Product Offerings
7.5.4 Affymatrix IVD Antibody Sales and Revenue in Global (2018-2023)
7.5.5 Affymatrix Key News & Latest Developments
7.6 BioLegend
7.6.1 BioLegend Company Summary
7.6.2 BioLegend Business Overview
7.6.3 BioLegend IVD Antibody Major Product Offerings
7.6.4 BioLegend IVD Antibody Sales and Revenue in Global (2018-2023)
7.6.5 BioLegend Key News & Latest Developments
7.7 Santa Cruz Biotechnologies
7.7.1 Santa Cruz Biotechnologies Company Summary
7.7.2 Santa Cruz Biotechnologies Business Overview
7.7.3 Santa Cruz Biotechnologies IVD Antibody Major Product Offerings
7.7.4 Santa Cruz Biotechnologies IVD Antibody Sales and Revenue in Global (2018-2023)
7.7.5 Santa Cruz Biotechnologies Key News & Latest Developments
7.8 Beckman Coulter
7.8.1 Beckman Coulter Company Summary
7.8.2 Beckman Coulter Business Overview
7.8.3 Beckman Coulter IVD Antibody Major Product Offerings
7.8.4 Beckman Coulter IVD Antibody Sales and Revenue in Global (2018-2023)
7.8.5 Beckman Coulter Key News & Latest Developments
7.9 Roche/Ventana
7.9.1 Roche/Ventana Company Summary
7.9.2 Roche/Ventana Business Overview
7.9.3 Roche/Ventana IVD Antibody Major Product Offerings
7.9.4 Roche/Ventana IVD Antibody Sales and Revenue in Global (2018-2023)
7.9.5 Roche/Ventana Key News & Latest Developments
8 Global IVD Antibody Production Capacity, Analysis
8.1 Global IVD Antibody Production Capacity, 2018-2029
8.2 IVD Antibody Production Capacity of Key Manufacturers in Global Market
8.3 Global IVD Antibody Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IVD Antibody Supply Chain Analysis
10.1 IVD Antibody Industry Value Chain
10.2 IVD Antibody Upstream Market
10.3 IVD Antibody Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IVD Antibody Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of IVD Antibody in Global Market
Table 2. Top IVD Antibody Players in Global Market, Ranking by Revenue (2022)
Table 3. Global IVD Antibody Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global IVD Antibody Revenue Share by Companies, 2018-2023
Table 5. Global IVD Antibody Sales by Companies, (K Units), 2018-2023
Table 6. Global IVD Antibody Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers IVD Antibody Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers IVD Antibody Product Type
Table 9. List of Global Tier 1 IVD Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IVD Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global IVD Antibody Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global IVD Antibody Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global IVD Antibody Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global IVD Antibody Sales (K Units), 2018-2023
Table 15. By Type - Global IVD Antibody Sales (K Units), 2024-2029
Table 16. By Application – Global IVD Antibody Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global IVD Antibody Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global IVD Antibody Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global IVD Antibody Sales (K Units), 2018-2023
Table 20. By Application - Global IVD Antibody Sales (K Units), 2024-2029
Table 21. By Region – Global IVD Antibody Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global IVD Antibody Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global IVD Antibody Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global IVD Antibody Sales (K Units), 2018-2023
Table 25. By Region - Global IVD Antibody Sales (K Units), 2024-2029
Table 26. By Country - North America IVD Antibody Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America IVD Antibody Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America IVD Antibody Sales, (K Units), 2018-2023
Table 29. By Country - North America IVD Antibody Sales, (K Units), 2024-2029
Table 30. By Country - Europe IVD Antibody Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe IVD Antibody Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe IVD Antibody Sales, (K Units), 2018-2023
Table 33. By Country - Europe IVD Antibody Sales, (K Units), 2024-2029
Table 34. By Region - Asia IVD Antibody Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia IVD Antibody Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia IVD Antibody Sales, (K Units), 2018-2023
Table 37. By Region - Asia IVD Antibody Sales, (K Units), 2024-2029
Table 38. By Country - South America IVD Antibody Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America IVD Antibody Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America IVD Antibody Sales, (K Units), 2018-2023
Table 41. By Country - South America IVD Antibody Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa IVD Antibody Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa IVD Antibody Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa IVD Antibody Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa IVD Antibody Sales, (K Units), 2024-2029
Table 46. BD PharMingen Company Summary
Table 47. BD PharMingen IVD Antibody Product Offerings
Table 48. BD PharMingen IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. BD PharMingen Key News & Latest Developments
Table 50. Abcam Company Summary
Table 51. Abcam IVD Antibody Product Offerings
Table 52. Abcam IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Abcam Key News & Latest Developments
Table 54. R&D Systems Company Summary
Table 55. R&D Systems IVD Antibody Product Offerings
Table 56. R&D Systems IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. R&D Systems Key News & Latest Developments
Table 58. Cell Signaling Technology Company Summary
Table 59. Cell Signaling Technology IVD Antibody Product Offerings
Table 60. Cell Signaling Technology IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Cell Signaling Technology Key News & Latest Developments
Table 62. Affymatrix Company Summary
Table 63. Affymatrix IVD Antibody Product Offerings
Table 64. Affymatrix IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Affymatrix Key News & Latest Developments
Table 66. BioLegend Company Summary
Table 67. BioLegend IVD Antibody Product Offerings
Table 68. BioLegend IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. BioLegend Key News & Latest Developments
Table 70. Santa Cruz Biotechnologies Company Summary
Table 71. Santa Cruz Biotechnologies IVD Antibody Product Offerings
Table 72. Santa Cruz Biotechnologies IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Santa Cruz Biotechnologies Key News & Latest Developments
Table 74. Beckman Coulter Company Summary
Table 75. Beckman Coulter IVD Antibody Product Offerings
Table 76. Beckman Coulter IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Beckman Coulter Key News & Latest Developments
Table 78. Roche/Ventana Company Summary
Table 79. Roche/Ventana IVD Antibody Product Offerings
Table 80. Roche/Ventana IVD Antibody Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Roche/Ventana Key News & Latest Developments
Table 82. IVD Antibody Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global IVD Antibody Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global IVD Antibody Production by Region, 2018-2023 (K Units)
Table 85. Global IVD Antibody Production by Region, 2024-2029 (K Units)
Table 86. IVD Antibody Market Opportunities & Trends in Global Market
Table 87. IVD Antibody Market Drivers in Global Market
Table 88. IVD Antibody Market Restraints in Global Market
Table 89. IVD Antibody Raw Materials
Table 90. IVD Antibody Raw Materials Suppliers in Global Market
Table 91. Typical IVD Antibody Downstream
Table 92. IVD Antibody Downstream Clients in Global Market
Table 93. IVD Antibody Distributors and Sales Agents in Global Market
List of Figures
Figure 1. IVD Antibody Segment by Type in 2022
Figure 2. IVD Antibody Segment by Application in 2022
Figure 3. Global IVD Antibody Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global IVD Antibody Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global IVD Antibody Revenue, 2018-2029 (US$, Mn)
Figure 7. IVD Antibody Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by IVD Antibody Revenue in 2022
Figure 9. By Type - Global IVD Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global IVD Antibody Revenue Market Share, 2018-2029
Figure 11. By Type - Global IVD Antibody Sales Market Share, 2018-2029
Figure 12. By Type - Global IVD Antibody Price (US$/Unit), 2018-2029
Figure 13. By Application - Global IVD Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global IVD Antibody Revenue Market Share, 2018-2029
Figure 15. By Application - Global IVD Antibody Sales Market Share, 2018-2029
Figure 16. By Application - Global IVD Antibody Price (US$/Unit), 2018-2029
Figure 17. By Region - Global IVD Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global IVD Antibody Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global IVD Antibody Revenue Market Share, 2018-2029
Figure 20. By Region - Global IVD Antibody Sales Market Share, 2018-2029
Figure 21. By Country - North America IVD Antibody Revenue Market Share, 2018-2029
Figure 22. By Country - North America IVD Antibody Sales Market Share, 2018-2029
Figure 23. US IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 24. Canada IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe IVD Antibody Revenue Market Share, 2018-2029
Figure 27. By Country - Europe IVD Antibody Sales Market Share, 2018-2029
Figure 28. Germany IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 29. France IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 31. Italy IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 32. Russia IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia IVD Antibody Revenue Market Share, 2018-2029
Figure 36. By Region - Asia IVD Antibody Sales Market Share, 2018-2029
Figure 37. China IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 38. Japan IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 41. India IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America IVD Antibody Revenue Market Share, 2018-2029
Figure 43. By Country - South America IVD Antibody Sales Market Share, 2018-2029
Figure 44. Brazil IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa IVD Antibody Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa IVD Antibody Sales Market Share, 2018-2029
Figure 48. Turkey IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 49. Israel IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 51. UAE IVD Antibody Revenue, (US$, Mn), 2018-2029
Figure 52. Global IVD Antibody Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production IVD Antibody by Region, 2022 VS 2029
Figure 54. IVD Antibody Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ IVD抗体の世界市場見通し2023年-2029年(IVD Antibody Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆